Among the single nucleotide polymorphisms (SNPs) in APOA5, the − 1131T > C variant (rs662799) in the promoter region was specifically associated with hyperglyceridemia and resulted in an increased risk of MetS, depending on the different populations [18]. Here, APOA5 is linked to metabolic syndrome.